Pediatric and young adult leukemia adoptive therapy (PLAT)-08: A phase 1 study of SC-DARIC33 in pediatric and young adults with relapsed or refractory CD33+ AML.

Authors

null

Todd Michael Cooper

Seattle Children's Hospital, Cancer and Blood Disorders Center, Seattle, WA

Todd Michael Cooper , Vicky Wu , Ashley Wilson , Jacob Appelbaum , Jordan Jarjour , Josh Gustafson , Stephanie Mgebroff , Catherine Lindgren , Christopher Brown , Michael C. Jensen , Julie R. Park , Rebecca Alice Gardner

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Track

Hematologic Malignancies

Sub Track

Other Leukemia, Myelodysplastic Syndromes, and Allotransplant

Clinical Trial Registration Number

NCT05105152

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr TPS7078)

DOI

10.1200/JCO.2022.40.16_suppl.TPS7078

Abstract #

TPS7078

Poster Bd #

301b

Abstract Disclosures

Similar Posters

First Author: Apostolia Maria Tsimberidou

First Author: David Stephen Shulman

First Author: Max S. Topp